Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1973 3
1974 1
1975 3
1976 3
1977 1
1978 3
1979 5
1980 6
1981 13
1982 8
1983 15
1984 13
1985 11
1986 10
1987 10
1988 13
1989 13
1990 22
1991 15
1992 13
1993 17
1994 23
1995 25
1996 12
1997 15
1998 10
1999 13
2000 17
2001 9
2002 15
2003 11
2004 13
2005 29
2006 19
2007 19
2008 19
2009 9
2010 9
2011 14
2012 16
2013 20
2014 17
2015 15
2016 15
2017 12
2018 9
2019 7
2020 10
2021 6
2022 5
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

576 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.
Jeppesen PB, Pertkiewicz M, Messing B, Iyer K, Seidner DL, O'keefe SJ, Forbes A, Heinze H, Joelsson B. Jeppesen PB, et al. Gastroenterology. 2012 Dec;143(6):1473-1481.e3. doi: 10.1053/j.gastro.2012.09.007. Epub 2012 Sep 11. Gastroenterology. 2012. PMID: 22982184 Clinical Trial.
Parenteral support was reduced if 48-hour urine volumes exceeded baseline values by 10%. ...Treatment with teduglutide reduced volumes and numbers of days of parenteral support for patients with SBS-IF; ClinicalTrials.gov Number, NCT00798967....
Parenteral support was reduced if 48-hour urine volumes exceeded baseline values by 10%. ...Treatment with teduglutide reduced volume
Analysis of risk factors for parenteral nutrition-associated cholestasis in preterm infants: a multicenter observational study.
Wang YS, Shen W, Yang Q, Lin R, Tang LX, Bai RM, Yang D, Zhang J, Zhang YJ, Yu WT, Song SR, Kong J, Song SY, Mao J, Tong XM, Li ZK, Wu F, Lin XZ. Wang YS, et al. BMC Pediatr. 2023 May 20;23(1):250. doi: 10.1186/s12887-023-04068-0. BMC Pediatr. 2023. PMID: 37210514 Free PMC article. Clinical Trial.
In contrast with the non-PNAC group, the PNAC group received a higher maximum dose of amino acids and fat emulsion, more medium/long-chain fatty emulsion, less SMOF, had a longer duration of parenteral nutrition, lower rates of breastfeeding, higher in …
In contrast with the non-PNAC group, the PNAC group received a higher maximum dose of amino acids and fat emulsion, more mediu …
Higher versus lower amino acid intake in parenteral nutrition for newborn infants.
Osborn DA, Schindler T, Jones LJ, Sinn JK, Bolisetty S. Osborn DA, et al. Cochrane Database Syst Rev. 2018 Mar 5;3(3):CD005949. doi: 10.1002/14651858.CD005949.pub2. Cochrane Database Syst Rev. 2018. PMID: 29505664 Free PMC article. Review.
OBJECTIVES: The primary objective is to determine whether higher versus lower intake of parenteral AA is associated with improved growth and disability-free survival in newborn infants receiving parenteral nutrition.Secondary objectives include determining wh …
OBJECTIVES: The primary objective is to determine whether higher versus lower intake of parenteral AA is associated with improved gro …
Early Amino Acids in Extremely Preterm Infants and Neurodisability at 2 Years.
Bloomfield FH, Jiang Y, Harding JE, Crowther CA, Cormack BE; ProVIDe Trial Group. Bloomfield FH, et al. N Engl J Med. 2022 Nov 3;387(18):1661-1672. doi: 10.1056/NEJMoa2204886. N Engl J Med. 2022. PMID: 36322845 Clinical Trial.
METHODS: In this multicenter, parallel-group, double-blind, randomized, placebo-controlled trial, we assigned infants with birth weights of less than 1000 g at 8 neonatal intensive care units to receive amino acids at a dose of 1 g per day (intervention group) or pl …
METHODS: In this multicenter, parallel-group, double-blind, randomized, placebo-controlled trial, we assigned infants with birth weights of …
WITHDRAWN: Nutrition support for bone marrow transplant patients.
Murray SM, Pindoria S. Murray SM, et al. Cochrane Database Syst Rev. 2017 Mar 23;3(3):CD002920. doi: 10.1002/14651858.CD002920.pub4. Cochrane Database Syst Rev. 2017. PMID: 28334434 Free PMC article. Review.
After treatment, patients can develop poor appetite, mucositis and gastrointestinal failure, leading to malnutrition. To prevent this, parenteral nutrition (PN) support is often first choice but is associated with increased risk of infection. ...AUTHORS' CONCLUSIONS …
After treatment, patients can develop poor appetite, mucositis and gastrointestinal failure, leading to malnutrition. To prevent this, pa
Early versus late parenteral nutrition for critically ill term and late preterm infants.
Moon K, Athalye-Jape GK, Rao U, Rao SC. Moon K, et al. Cochrane Database Syst Rev. 2020 Apr 8;4(4):CD013141. doi: 10.1002/14651858.CD013141.pub2. Cochrane Database Syst Rev. 2020. PMID: 32266712 Free PMC article.
BACKGROUND: Recently conducted randomised controlled trials (RCTs) suggest that late commencement of parenteral nutrition (PN) may have clinical benefits in critically ill adults and children. ...
BACKGROUND: Recently conducted randomised controlled trials (RCTs) suggest that late commencement of parenteral nutrition (PN) …
Effects of nutritional interventions on nutritional status in patients with gastric cancer: A systematic review and meta-analysis of randomized controlled trials.
Rinninella E, Cintoni M, Raoul P, Pozzo C, Strippoli A, Bria E, Tortora G, Gasbarrini A, Mele MC. Rinninella E, et al. Clin Nutr ESPEN. 2020 Aug;38:28-42. doi: 10.1016/j.clnesp.2020.05.007. Epub 2020 Jun 16. Clin Nutr ESPEN. 2020. PMID: 32690170
A growing number of randomized controlled trials (RCTs) evaluated different nutritional strategies - oral nutritional supplements (ONS), enteral nutrition (EN), enteral immunonutrition (EIN), parenteral nutrition (PN) and nutritional counselling - in GC patie …
A growing number of randomized controlled trials (RCTs) evaluated different nutritional strategies - oral nutritional supplements (ONS), ent …
Nutrition support for bone marrow transplant patients.
Murray SM, Pindoria S. Murray SM, et al. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD002920. doi: 10.1002/14651858.CD002920.pub3. Cochrane Database Syst Rev. 2009. PMID: 19160213 Updated. Review.
After treatment, patients can develop poor appetite, mucositis and gastrointestinal failure, leading to malnutrition. To prevent this, parenteral nutrition (PN) support is often first choice but is associated with increased risk of infection. ...AUTHORS' CONCLUSIONS …
After treatment, patients can develop poor appetite, mucositis and gastrointestinal failure, leading to malnutrition. To prevent this, pa
Glutamine dipeptide-supplemented parenteral nutrition improves the clinical outcomes of critically ill patients: A systematic evaluation of randomised controlled trials.
Stehle P, Ellger B, Kojic D, Feuersenger A, Schneid C, Stover J, Scheiner D, Westphal M. Stehle P, et al. Clin Nutr ESPEN. 2017 Feb;17:75-85. doi: 10.1016/j.clnesp.2016.09.007. Epub 2016 Oct 27. Clin Nutr ESPEN. 2017. PMID: 28361751 Review.
BACKGROUND & AIMS: Early randomised controlled trials (RCTs) testing whether parenteral nutrition regimens that include glutamine dipeptides improves the outcomes of critically ill patients demonstrated convincingly that this regimen associates with reduced mort …
BACKGROUND & AIMS: Early randomised controlled trials (RCTs) testing whether parenteral nutrition regimens that include gl …
Randomized controlled phase I trial for a novel peripheral parenteral nutrition formula containing dextrose, amino acids, fat emulsion, electrolytes, and FDA2000 recommendation-based vitamins.
Fukatsu K, Shineha R, Katayose S, Kawauchi Y, Nakayama M. Fukatsu K, et al. Clin Nutr ESPEN. 2022 Aug;50:41-48. doi: 10.1016/j.clnesp.2022.05.001. Epub 2022 May 13. Clin Nutr ESPEN. 2022. PMID: 35871950 Free article. Clinical Trial.
BACKGROUND & AIMS: We developed the world's first all-in-one type peripheral parenteral nutrition product containing dextrose, amino acids, fat emulsion, electrolytes and vitamins, according to the FDA 2000 recommendation. ...Participants were admi …
BACKGROUND & AIMS: We developed the world's first all-in-one type peripheral parenteral nutrition product containing dextr …
576 results